- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06877871
Combined Effects of Whole Body Vibration and Abdominal Binders on Outcome Measures of Constipation in Postnatal Women
March 10, 2025 updated by: Riphah International University
Constipation is a prevalent issue among postnatal women, often resulting in significant discomfort and reduced quality of life.
Traditional treatments like dietary adjustments and laxatives frequently provide only temporary relief and may lead to dependency.
Whole-body vibration therapy and abdominal binders have emerged as promising non-invasive interventions for improving bowel function and relieving constipation.
Study Overview
Status
Completed
Conditions
Detailed Description
Constipation is a complex condition arising due to many interrelated causes.
Dietary inadequacies, most notably for fiber or fluid, often constitute a centerpiece of constipation.
But other lifestyle factors including lack of movement and irregular bowel movements are also to blame.
Known conditions affecting the gut motility, from medical perspective, include irritable bowel syndrome (IBS), diabetes, hypothyroidism, and neurological disorders including Parkinson's disease.
Often listed as a side effect in medications such as opiates, antacids and antidepressants for example.
Additionally, gut brain axis demonstrates that psychological aspects play a substantial part in the well being of the gut, since stress and anxiety frequently make matters worse.
It is important to understand the causes of constipation to develop treatments.It is usually described as occurring less than three times per week, difficult to pass stools or passage of stools that does not feel satisfactory.
Whereas, acute constipation can be often attributed to alteration in diet and water intake or stress, the chronic constipation is a long-standing pathological entity which can negatively affect the quality of life.
Whole body vibration therapy (WBV) is a therapeutic modality that utilizes mechanical vibrations to excite muscle, nerve and tissue structures in the body.
WBV is typically administered on a vibrating platform where the device is either controlled to deliver vibrations at specified frequencies and amplitudes as the individual performs a standing, sitting, or lying position.
The vibrations produce rapid, involuntary muscle contractions- and result in a similar exercising effect without the impact to your body.
Abdominal binders are conventionally used for physical support but recent evidence supports their use in improving bowel function as increased abdominal muscle recruitment and intra-abdominal pressure, both integral to a healthy peristaltic push.
Study Type
Interventional
Enrollment (Actual)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan
- Riphah International University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Females age 22-35 years
- Females underwent C-section were included in the study
- Participants who had severe constipation
- Primary gravida
- Women who had 6 months of Postpartum period
- Single fetus pregnancy
Exclusion Criteria:
- Females who had normal delivery were excluded
- History of episiotomy
- Participants taking laxative were excluded
- History of post cesarean abdominal suture infections
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group: Whole body vibration
WBV was developed initially for fitness and physical rehabilitation and has been moving into other areas of healthcare such as pain management and neurological recovery and improving circulation.
whole body vibration (WBV) therapy for the body eases the physical functions of muscular and circulatory.
Additionally, mechanical aids (e.g.
abdominal binders) have been explored as support for abdominal region and proper posture, which in turn secondarily aid gastrointestinal function
|
(WBV) is a therapeutic modality that utilizes mechanical vibrations to excite muscle, nerve and tissue structures in the body.
WBV was developed initially for fitness and physical rehabilitation and has been moving into other areas of healthcare such as pain management and neurological recovery and improving circulation.However, this activation can help to elevate intestinal motility, reduce bloating and help overall digestion.
Other Names:
|
|
Experimental: Experimental group: Abdominal binders
Abdominal binders are designed primarily to help patients who have suffered abdominal trauma to stabilize core muscles, reduce pain, and improve mobility.
Improved posture, better breathing and a reduction of strain on the lower back are also aided by creating gentle pressure on the abdomen.
Abdominal binders are conventionally used for physical support but recent evidence supports their use in improving bowel function as increased abdominal muscle recruitment and intra-abdominal pressure, both integral to a healthy peristaltic push.
|
(WBV) is a therapeutic modality that utilizes mechanical vibrations to excite muscle, nerve and tissue structures in the body.
WBV was developed initially for fitness and physical rehabilitation and has been moving into other areas of healthcare such as pain management and neurological recovery and improving circulation.However, this activation can help to elevate intestinal motility, reduce bloating and help overall digestion.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient assessment of constipation symptoms (PAC-SYM) Questionnaire It
Time Frame: A total of 18 sessions were conducted over a period of 6 weeks,
|
It is frequently used in clinical trials of constipation.
It is an important tool for assessing the severity of patient reported symptoms of constipation.
The 12-item questionnaire is divided into three symptom sub scales: abdominal (four items); rectal (three items); and stool (five items).
Items are scored on 5-point Likert scales, with scores ranging from 0 to 4 (0 = 'symptom absent', 1 = 'mild', 2 = 'moderate', 3 = 'severe' and 4 = 'very severe').
|
A total of 18 sessions were conducted over a period of 6 weeks,
|
|
Patient assessment of constipation quality of life (PAC-QOL) Questionnaire
Time Frame: A total of 18 sessions were conducted over a period of 6 weeks,
|
The PAC-QOL questionnaire is sub categorized to 4 items on physical discomfort, 8 items on psycho social discomfort, 5 items on treatment satisfaction, and finally 11 items on worries and discomfort.
Response choice is a Likert scale from 0 to 4.
|
A total of 18 sessions were conducted over a period of 6 weeks,
|
|
Modified constipation assessment scale (MCAS)
Time Frame: A total of 18 sessions were conducted over a period of 6 weeks,
|
It is used to assess bowel function.
It consists of a 3-point summated rating scale (0 = no problem ; 1 = some problem ; 2 = severe problem ) resulting in a total score that ranges from 0 ( no constipation ) to 16 ( severe constipation ).
|
A total of 18 sessions were conducted over a period of 6 weeks,
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Adeela Arif, MS, Riphah International University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 19, 2023
Primary Completion (Actual)
February 2, 2025
Study Completion (Actual)
February 2, 2025
Study Registration Dates
First Submitted
March 10, 2025
First Submitted That Met QC Criteria
March 10, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 10, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Iqra Ishtiaq
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Constipation
-
Peking Union Medical College HospitalInstitute of Process Engineering, Chinese Academy of SciencesNot yet recruitingChronic Constipation | Constipation - Functional | Fecal Microbiota TransplantationChina
-
Hamilton Health Sciences CorporationNot yet recruitingConstipation | Constipation - Functional | Constipation AggravatedCanada
-
Singapore Institute of TechnologyNot yet recruitingConstipation | Diet Modification | Constipation-predominant Irritable Bowel Syndrome | Diet Therapy | Constipation - Functional | Constipation Chronic Idiopathic | Constipation, Signs and Symptoms, Digestive | Dietary Fiber | Dietary Fibers | Constipation Predominant Irritable Bowel Syndrome | Dietary and... and other conditionsSingapore
-
Institute of Medical Sciences and SUM HospitalNot yet recruitingFunctional Constipation | Constipation - Functional | Constipation Chronic Idiopathic | Fecal Impaction | Pediatric Functional ConstipationIndia
-
Peking Union Medical College HospitalRecruitingChronic Constipation | Constipation - Functional | Fecal Microbiota Transplantation (FMT)China
-
SK Life Science, Inc.CompletedChronic Constipation | Functional ConstipationUnited States
-
Hong Kong Metropolitan UniversityNot yet recruitingConstipation | Constipation Drug Induced | Psychiatric Drug Induced ConstipationHong Kong
-
usMIMA S.L.CompletedConstipation | Constipation Chronic Idiopathic | Constipation; NeurogenicSpain, United Kingdom
-
Selin KoşanActive, not recruitingChronic Constipation | Functional Constipation | Pelvic Floor | Biofeedback | Diaphragmatic BreathingTurkey (Türkiye)
-
Hong Kong Metropolitan UniversityHospital Authority, Hong KongRecruitingConstipation | Constipation Drug Induced | Psychiatric Drug Induced ConstipationHong Kong